STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced its participation in the Oppenheimer MedTech, Tools & Diagnostics Summit on May 26, 2021. The presentation will be available on-demand, showcasing the company's innovative dermatologic treatment technologies like the XTRAC® excimer laser and VTRAC® lamp systems. These products target conditions affecting over 31 million patients in the U.S., including psoriasis and vitiligo. STRATA employs a Direct to Consumer advertising model to boost awareness and support its partner dermatology clinics.

Positive
  • None.
Negative
  • None.

HORSHAM, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming Oppenheimer MedTech, Tools & Diagnostics Summit.

Dates: Wednesday May 26th, 2021
Format: Presentation available on demand beginning Wednesday May 26th
A link to the presentation will be available on the “Investors” section of the Company’s website at www.strataskinsciences.com.

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® excimer laser and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

The Company’s proprietary XTRAC excimer laser delivers a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. The technology is covered by multiple patents.

STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contacts:

Leigh Salvo
(415) 937-5404
ir@strataskin.com

 


FAQ

What is STRATA Skin Sciences presenting at the Oppenheimer MedTech Summit on May 26, 2021?

STRATA Skin Sciences will present its innovative products for treating dermatologic conditions, including the XTRAC® excimer laser.

How can I access STRATA Skin Sciences' presentation from the Oppenheimer MedTech Summit?

The presentation will be available on-demand on STRATA Skin Sciences' website starting May 26, 2021.

What dermatologic conditions does STRATA Skin Sciences' technology address?

STRATA's technology treats conditions such as psoriasis, vitiligo, eczema, and atopic dermatitis.

How many patients in the U.S. are affected by the conditions treated by STRATA Skin Sciences?

Over 31 million patients in the U.S. are affected by the conditions that STRATA Skin Sciences treats.

What business model does STRATA Skin Sciences use to promote its products?

STRATA utilizes targeted Direct to Consumer advertising and has dedicated call center and insurance advocacy teams.

Strata Skin Sciences, Inc.

NASDAQ:SSKN

SSKN Rankings

SSKN Latest News

SSKN Stock Data

12.64M
2.61M
2.91%
60.39%
0.13%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
HORSHAM